Table 1. Association between clinicopathologic characteristics and DTL expression.
| n | DTL immunoreactivity | P value* | ||
|---|---|---|---|---|
| high expression | low expression | |||
| Total | 100 | 42 (42%) | 58 (58%) | |
| Gender | ||||
| Male | 59 | 29 (69%) | 30 (52%) | 0.0821 |
| Female | 41 | 13 (31%) | 28 (48%) | |
| Age (y) | ||||
| Mean 61.22 (range:28–87) | ||||
| <60 | 40 | 16 (38%) | 24 (41%) | 0.7407 |
| ≥60 | 60 | 26 (62%) | 34 (59%) | |
| Histopathological grading | ||||
| Differentiated | 45 | 20 (48%) | 25 (43%) | 0.6542 |
| Undifferentiated | 55 | 22 (52%) | 33 (57%) | |
| Tumor size (mm) | ||||
| < 25 | 32 | 12 (28%) | 20 (34%) | 0.5317 |
| ≥25 | 68 | 30 (72%) | 38 (66%) | |
| Venous invasion | ||||
| v0 | 72 | 27 (64%) | 45 (78%) | 0.1462 |
| v1–2 | 25 | 15 (36%) | 10 (17%) | |
| v3 | 3 | 0 (0%) | 3 (5%) | |
| Lymphatic invasion | ||||
| ly0 | 55 | 16 (38%) | 39 (67%) | 0.0137 |
| ly1–2 | 39 | 24 (57%) | 15 (26%) | |
| ly3 | 6 | 2 (5%) | 4 (7%) | |
| TNM classification | ||||
| pT categories | ||||
| pT1–3 | 78 | 28 (67%) | 50 (81%) | 0.0199 |
| pT4 | 22 | 14 (33%) | 8 (19%) | |
| pN categories | ||||
| pN0–2 | 84 | 33 (79%) | 51 (86%) | 0.2076 |
| pN3 | 16 | 9 (21%) | 7 (14%) | |
| Recurrennce | ||||
| Absent | 78 | 28 (67%) | 50 (81%) | 0.0199 |
| Present | 22 | 14 (33%) | 8 (19%) | |
NOTE. Significant values are in bold type.
*
P values are from χ2 or Fisher's exact test and were significant at <0.05.